Biotech firm stocks rise on FDA vaccine head's exit
Source: SeekingAlpha
2026-03-09 09:40:31 ET
More on uniQure, Regenxbio, etc.
- Assessing Where Regenxbio Stands After FY25 Results
- REGENXBIO Inc. (RGNX) Q4 2025 Earnings Call Transcript
- uniQure: Worst Case Scenario Becomes Reality
- uniQure surges following departure of key FDA official
- Solid Biosciences announces $240 million private placement
Read the full article on Seeking Alpha
For further details see:
Biotech firm stocks rise on FDA vaccine head’s exit
Capricor Therapeutics Inc.
NASDAQ: CAPR
CAPR Trading
-6.86% G/L:
$30.97 Last:
1,644,147 Volume:
$33 Open:
CAPR Latest News
CAPR Stock Data
$1,278,443,622
46,286,693
0.54%
28
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
